Aduhelm Could Help Drug Pricing Bill Regain Traction, But Congress, CMS Mostly Quiet

By John Wilkerson / June 14, 2021 at 4:25 PM
A single drug, Sovaldi, started a debate over drug prices in 2014, and now the Alzheimer’s drug Aduhelm might help Congress regain a grip on drug pricing legislation just as it was slipping away. But a lot is up in the air; key congressional Democrats are considering adding Medicare price negotiation to the president’s American Families Plan and passing it with a party-line vote, but the odds are long on that happening. The plan is to first strike a bipartisan...


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.